5
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1824 |
TGR5 Receptor Agonist
|
GPCR19 | GPCR/G Protein |
TGR5 Receptor Agonist 是一种TGR5(GPCR19)激动剂。 | |||
T63584 | ATX inhibitor 12 | ||
ATX inhibitor 12 是口服具有活力的 ATX 抑制剂 (IC50: 1.72 nM)。在 C57Bl/6J 小鼠中,口服剂量为 60 mg/kg 的 ATX inhibitor 12 时,能够有效抑制肺结构损伤,降低纤维化病变。ATX inhibitor 12 能够用于研究特发性肺纤维化 (IPF) 。 | |||
T23945 |
DA-11004
DA11004,UNII-48M66E9ER2 |
||
DA-11004 is a potent NADP-dependent isocitrate dehydrogenase inhibitor (IC50: 1.49 μM for IDPc). DA-11004 inhibited fatty acid synthesis in adipose tissues via IDPc inhibition. It also decreased the plasma glucose levels and FFA in HF diet-induced obesity | |||
T15043 | D5D-IN-326 | Others | Others |
D5D-IN-326 is an orally active delta-5 desaturase (D5D) inhibitor (IC50s: 72 and 22 nM for rat and human D5D in enzymic and cell-based assays). It has no effect on D6D or D9D activity. D5D-IN-326 reduces insulin resistance and decreases body weight in die | |||
T36296 | BIO5192 hydrate | ||
BIO5192 hydrate is a selective and potent integrin α4β1 (VLA-4) inhibitor (Kd<10 pM). BIO5192 hydrate selectively binds to α4β1 (IC50=1.8 nM) over a range of other integrins. BIO5192 hydrate results in a 30-fold increase in mobilization of murine hematopoietic stem and progenitors (HSPCs) over basal levels[1][2]. The combination of BIO5192 hydrate (1 mg/kg; i.v.) and Plerixafor (5 mg/kg; s.c.) exert an additive effect on progenitor mobilization[1].BIO5192 hydrate (30 mg/kg; s.c; bid; during days... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7036 |
2,4'-Dihydroxybenzophenone
|
Antioxidant | oxidation-reduction |
2,4'-Dihydroxybenzophenone 可有效保护 C57BL/6J 小鼠免受 APAP 诱导的肝毒性。它对可卡因诱导的小鼠急性肝毒性和神经毒性具有保护作用。其机制可能与其抗氧化活性有关。 |